Corcept Therapeutics reported $128K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Ani Pharmaceuticals ANIP:US $ 0M 0M
Aurora Cannabis Inc ACB:CN 6.57B 141.91M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Canopy Growth Corp WEED:CN C$ 7.6B 118.76M
Corcept Therapeutics CORT:US $ 0.13M 0M
Depomed DEPO:US $ 0M 0M
Eleven Biotherapeutics EBIO:US $ 0.2M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Esperion Therapeutics ESPR:US $ 65K 4K
Knight Therapeutics Inc GUD:CN C$ 619.67M 9.18M
Lannett LCI:US $ 0.04M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 890M 11M
Novartis NVS:US $ 890M 11M
Pacira Pharmaceuticals PCRX:US $ 0.05M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Ziopharm Oncology ZIOP:US $ 0.22M 0M